In conclusion, strong evidence suggests that expression of SETD7 is predictive of a poor outcome for patients carrying basal-like tumours, even though this subtype has lower SETD7 expression in comparison to the luminal A or Her2-enriched subtypes (Figure 1B,C). Here, ERBB2 is linked to neoplasm.